Jiang S - Search Results

1

Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression.

Wang H, Zhou X, Wang Z, Lu T, Li B, Jiang S. Wang H, et al. Among authors: jiang s. Evid Based Complement Alternat Med. 2022 May 25;2022:3032087. doi: 10.1155/2022/3032087. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Dec 13;2023:9820926. doi: 10.1155/2023/9820926 PMID: 35664943 Free PMC article. Retracted.

2

Carnosic Acid Induces Antiproliferation and Anti-Metastatic Property of Esophageal Cancer Cells via MAPK Signaling Pathways.

Jiang S, Qiu Y, Wang Z, Ji Y, Zhang X, Yan X, Zhan Z. Jiang S, et al. J Oncol. 2021 Nov 16;2021:4451533. doi: 10.1155/2021/4451533. eCollection 2021. J Oncol. 2021. PMID: 34824582 Free PMC article.

3

The Impact of Catalpol on Proliferation, Apoptosis, Migration, and Oxidative Stress of Lung Cancer Cells Based on Nrf2/ARE Signaling.

Wang H, Wu J, Fan H, Ji Y, Han C, Li C, Jiang S. Wang H, et al. Among authors: jiang s. Biomed Res Int. 2022 Jul 18;2022:5621341. doi: 10.1155/2022/5621341. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2024 Jan 9;2024:9860506. doi: 10.1155/2024/9860506 PMID: 35898682 Free PMC article. Retracted.

4

A study on expression level and nutritional status of IGFBP-2 after left neck anastomosis combined with placement of feeding nutritional applicators carrying ^(125)I particles in the treatment of esophageal cancer.

Zhan Z, Mei J, Zhou X, Jiang S, Li D, Wang X. Zhan Z, et al. Among authors: jiang s. Front Oncol. 2022 Dec 6;12:1085305. doi: 10.3389/fonc.2022.1085305. eCollection 2022. Front Oncol. 2022. Retraction in: Front Oncol. 2024 Feb 21;14:1383394. doi: 10.3389/fonc.2024.1383394 PMID: 36561518 Free PMC article. Retracted.

5

Identification of immune-related genes contributing to head and neck squamous cell carcinoma development using weighted gene co-expression network analysis.

Guo Q, Lu T, Xu H, Luo Q, Liu Z, Jiang S, Pan J, Lin S, Lin M, Guo F. Guo Q, et al. Among authors: jiang s. Cancer Rep (Hoboken). 2023 May;6(5):e1808. doi: 10.1002/cnr2.1808. Epub 2023 Apr 24. Cancer Rep (Hoboken). 2023. PMID: 37092360 Free PMC article.

6

Efficacy and safety of camrelizumab combined with albumin-bound paclitaxel as third- or later-line regimen in patients with advanced non-small cell lung cancer.

Zhu J, Yu Y, Mei J, Chen S, Li J, Jiang S. Zhu J, et al. Among authors: jiang s. Front Immunol. 2023 Dec 6;14:1278573. doi: 10.3389/fimmu.2023.1278573. eCollection 2023. Front Immunol. 2023. PMID: 38124737 Free PMC article.

7

Value of prognostic nutritional index and controlling nutritional status score for advanced non-small cell lung cancer patients receiving PD-1 inhibitors.

Jiang S, Wang X, Xing Y, Wu J, Yuan X. Jiang S, et al. Am J Cancer Res. 2024 Jun 15;14(6):2894-2904. doi: 10.62347/XQHL4852. eCollection 2024. Am J Cancer Res. 2024. PMID: 39005673 Free PMC article.

8

Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.

Jiang S, Liu X, Li D, Yan M, Ju C, Sun J, Jiang F. Jiang S, et al. Among authors: jiang f. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818797587. doi: 10.1177/1533033818797587. Technol Cancer Res Treat. 2018. Retraction in: Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218448. doi: 10.1177/15330338231218448 PMID: 30198403 Free PMC article. Retracted.

9

The relative and absolute benefit of programmed death receptor-1 vs programmed death ligand 1 therapy in advanced non-small-cell lung cancer: A systematic review and meta-analysis.

Yi K, Zhu Q, Kuang YK, Jiang SC, Hu H. Yi K, et al. Int Immunopharmacol. 2020 Oct;87:106852. doi: 10.1016/j.intimp.2020.106852. Epub 2020 Aug 3. Int Immunopharmacol. 2020. PMID: 32759049

10

Brain Metastases Status and Immunotherapy Efficacy in Advanced Lung Cancer: A Systematic Review and Meta-Analysis.

Hu H, Xu ZY, Zhu Q, Liu X, Jiang SC, Zheng JH. Hu H, et al. Front Immunol. 2021 Jul 14;12:669398. doi: 10.3389/fimmu.2021.669398. eCollection 2021. Front Immunol. 2021. PMID: 34335570 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,858 results

Search Page

Filters